These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34959315)

  • 1. Nanoantibiotics Based in Mesoporous Silica Nanoparticles: New Formulations for Bacterial Infection Treatment.
    Álvarez E; González B; Lozano D; Doadrio AL; Colilla M; Izquierdo-Barba I
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment.
    Colilla M; Vallet-Regí M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Bioglasses Enriched with Bioactive Agents for Bone Repair, with a Special Highlight of María Vallet-Regí's Contribution.
    Salinas AJ; Esbrit P
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment.
    González B; Colilla M; Díez J; Pedraza D; Guembe M; Izquierdo-Barba I; Vallet-Regí M
    Acta Biomater; 2018 Mar; 68():261-271. PubMed ID: 29307796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles.
    Zhu CL; Wang XW; Lin ZZ; Xie ZH; Wang XR
    J Food Drug Anal; 2014 Mar; 22(1):18-28. PubMed ID: 24673901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Use of Nanostructured Silica-Based Materials Functionalized with Metallodrugs: The Spanish Perspective.
    Díaz-García D; Prashar S; Gómez-Ruiz S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronology of Global Success: 20 Years of Prof Vallet-Regí Solving Questions.
    Manzano M
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica-based mesoporous nanoparticles for controlled drug delivery.
    Kwon S; Singh RK; Perez RA; Abou Neel EA; Kim HW; Chrzanowski W
    J Tissue Eng; 2013; 4():2041731413503357. PubMed ID: 24020012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our contributions to applications of mesoporous silica nanoparticles.
    Vallet-Regí M
    Acta Biomater; 2022 Jan; 137():44-52. PubMed ID: 34653693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of surface capped mesoporous silica nanoparticles for pH-stimuli responsive drug delivery applications.
    Santha Moorthy M; Bharathiraja S; Manivasagan P; Lee KD; Oh J
    Medchemcomm; 2017 Sep; 8(9):1797-1805. PubMed ID: 30108889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles in target drug delivery system: A review.
    Bharti C; Nagaich U; Pal AK; Gulati N
    Int J Pharm Investig; 2015; 5(3):124-33. PubMed ID: 26258053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates.
    Gisbert-Garzarán M; Vallet-Regí M
    Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erianin-Loaded Photo-Responsive Dendrimer Mesoporous Silica Nanoparticles: Exploration of a Psoriasis Treatment Method.
    Yu H; Liu Y; Zheng F; Chen W; Wei K
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mesoporous silica nanoparticles for cancer theranostic drug delivery].
    Wang X; Teng ZG; Huang XY; Lu GM
    Yao Xue Xue Bao; 2013 Jan; 48(1):8-13. PubMed ID: 23600135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
    Baeza A; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
    Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
    J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
    Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
    Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.
    Gisbert-Garzarán M; Manzano M; Vallet-Regí M
    Bioengineering (Basel); 2017 Jan; 4(1):. PubMed ID: 28952481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.